P. J. Mease
P. Foley
K. Reich
M. Lebwohl
Y. W. Yang
M. Shawi
M. Miller
A. Kollmeier
E. C. Hsia
X. L. Xu
P. Ramachandran
S. Sheng
Y. You
P. Helliwell
W. H. Boehncke
2Swedish Medical Center/Providence St. Joseph Health and University of Washington, Rheumatology, Seattle, Washington, United States of America
The University of Melbourne, St. Vincent’s Hospital Melbourne and Probity Medical Research, Skin Health Institute, Department of Medicine, Carlton, Australia
University Medical Center Hamburg-Eppendorf, Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, Hamburg, Germany
Psoriasis Treatment Center of Central New Jersey, Department of Dermatology, East Windsor, United States of America
Icahn School of Medicine at Mount Sinai, Department of Health Evidence and Policy, New York, United States
, Janssen Global Services, LLC, Horsham, PA, United States of America
Janssen Research & Development, Raritan, United States of America
Janssen Research & Development, LLC, Immunology, San Diego, CA, United States of America
University of Pennsylvania School of Medicine, Immunology, Philadelphia, United States of America
Janssen Research & Development, Raritan, United States of America
University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom
United States
Australia
Germany
United Kingdom
Switzerland
N/A
Ophthalmology (OP)
Uveitis
N/A
guselkumab (IV)
N/A
Placebo Control
Controlled
III
N/A
Abbvie
N/A